CN106880050A - 一种五环互促微生组调节情绪的药食及其制备方法 - Google Patents
一种五环互促微生组调节情绪的药食及其制备方法 Download PDFInfo
- Publication number
- CN106880050A CN106880050A CN201710021235.2A CN201710021235A CN106880050A CN 106880050 A CN106880050 A CN 106880050A CN 201710021235 A CN201710021235 A CN 201710021235A CN 106880050 A CN106880050 A CN 106880050A
- Authority
- CN
- China
- Prior art keywords
- parts
- lactobacillus
- group
- vitamin
- bifidobacterium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 28
- 230000033228 biological regulation Effects 0.000 title claims abstract description 24
- 230000036651 mood Effects 0.000 title claims abstract description 22
- 239000003814 drug Substances 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 230000004060 metabolic process Effects 0.000 claims abstract description 19
- 239000002858 neurotransmitter agent Substances 0.000 claims abstract description 16
- 210000004556 brain Anatomy 0.000 claims abstract description 15
- 244000005700 microbiome Species 0.000 claims abstract description 13
- 239000004615 ingredient Substances 0.000 claims abstract description 9
- 235000013406 prebiotics Nutrition 0.000 claims abstract description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 36
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 36
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 32
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 claims description 24
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 24
- 239000000284 extract Substances 0.000 claims description 22
- 241001506047 Tremella Species 0.000 claims description 19
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 18
- 229960003180 glutathione Drugs 0.000 claims description 18
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 18
- 108010024636 Glutathione Proteins 0.000 claims description 17
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 17
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 17
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 16
- 229930003268 Vitamin C Natural products 0.000 claims description 16
- 235000019154 vitamin C Nutrition 0.000 claims description 16
- 239000011718 vitamin C Substances 0.000 claims description 16
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims description 15
- 229940088594 vitamin Drugs 0.000 claims description 15
- 229930003231 vitamin Natural products 0.000 claims description 15
- 235000013343 vitamin Nutrition 0.000 claims description 15
- 239000011782 vitamin Substances 0.000 claims description 15
- 229940011671 vitamin b6 Drugs 0.000 claims description 15
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 15
- 102000019197 Superoxide Dismutase Human genes 0.000 claims description 14
- 108010012715 Superoxide dismutase Proteins 0.000 claims description 14
- 150000004676 glycans Chemical class 0.000 claims description 14
- 229920001282 polysaccharide Polymers 0.000 claims description 14
- 239000005017 polysaccharide Substances 0.000 claims description 14
- 235000019158 vitamin B6 Nutrition 0.000 claims description 14
- 239000011726 vitamin B6 Substances 0.000 claims description 14
- 244000246386 Mentha pulegium Species 0.000 claims description 13
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 13
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 13
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 13
- 235000001050 hortel pimenta Nutrition 0.000 claims description 13
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims description 12
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 claims description 12
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 12
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 12
- 229930003779 Vitamin B12 Natural products 0.000 claims description 12
- 229960000304 folic acid Drugs 0.000 claims description 12
- 235000019152 folic acid Nutrition 0.000 claims description 12
- 239000011724 folic acid Substances 0.000 claims description 12
- 229960000367 inositol Drugs 0.000 claims description 12
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 12
- 229940026510 theanine Drugs 0.000 claims description 12
- 235000019163 vitamin B12 Nutrition 0.000 claims description 12
- 239000011715 vitamin B12 Substances 0.000 claims description 12
- 244000068988 Glycine max Species 0.000 claims description 11
- 235000010469 Glycine max Nutrition 0.000 claims description 11
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 11
- 238000004806 packaging method and process Methods 0.000 claims description 11
- 229920001202 Inulin Polymers 0.000 claims description 9
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 9
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 9
- 240000001929 Lactobacillus brevis Species 0.000 claims description 9
- 235000013957 Lactobacillus brevis Nutrition 0.000 claims description 9
- 241000186840 Lactobacillus fermentum Species 0.000 claims description 9
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 9
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 9
- 241000186869 Lactobacillus salivarius Species 0.000 claims description 9
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 9
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 9
- 229960002079 calcium pantothenate Drugs 0.000 claims description 9
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 9
- 229940029339 inulin Drugs 0.000 claims description 9
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 9
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 9
- 229940035901 lactobacillus sp Drugs 0.000 claims description 9
- 229960004488 linolenic acid Drugs 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 229920001542 oligosaccharide Polymers 0.000 claims description 9
- 150000002482 oligosaccharides Chemical class 0.000 claims description 9
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 9
- 235000013824 polyphenols Nutrition 0.000 claims description 9
- 229960003495 thiamine Drugs 0.000 claims description 9
- 241000186018 Bifidobacterium adolescentis Species 0.000 claims description 8
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 claims description 8
- 229930003451 Vitamin B1 Natural products 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 8
- 229940004120 bifidobacterium infantis Drugs 0.000 claims description 8
- 229960003512 nicotinic acid Drugs 0.000 claims description 8
- 235000001968 nicotinic acid Nutrition 0.000 claims description 8
- 239000011664 nicotinic acid Substances 0.000 claims description 8
- 235000010374 vitamin B1 Nutrition 0.000 claims description 8
- 239000011691 vitamin B1 Substances 0.000 claims description 8
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 7
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 7
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims description 7
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 7
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 claims description 6
- 241001608472 Bifidobacterium longum Species 0.000 claims description 6
- 241000196324 Embryophyta Species 0.000 claims description 6
- 244000199866 Lactobacillus casei Species 0.000 claims description 6
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 6
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 6
- 241000194041 Lactococcus lactis subsp. lactis Species 0.000 claims description 6
- 240000003394 Malpighia glabra Species 0.000 claims description 6
- 235000014837 Malpighia glabra Nutrition 0.000 claims description 6
- 235000014969 Streptococcus diacetilactis Nutrition 0.000 claims description 6
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 6
- 229940087603 grape seed extract Drugs 0.000 claims description 6
- 235000002532 grape seed extract Nutrition 0.000 claims description 6
- 229940017800 lactobacillus casei Drugs 0.000 claims description 6
- 239000001717 vitis vinifera seed extract Substances 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 210000000481 breast Anatomy 0.000 claims description 4
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- VZRRCQOUNSHSGB-UHFFFAOYSA-N 4-hydroxy-4,6,6-trimethylbicyclo[3.1.1]heptan-3-one Chemical compound C1C2C(C)(C)C1CC(=O)C2(O)C VZRRCQOUNSHSGB-UHFFFAOYSA-N 0.000 claims description 3
- -1 5HTP Chemical compound 0.000 claims description 3
- 240000002900 Arthrospira platensis Species 0.000 claims description 3
- 235000016425 Arthrospira platensis Nutrition 0.000 claims description 3
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 3
- 241000062052 Bifidobacterium longum subsp. longum 1-6B Species 0.000 claims description 3
- SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 claims description 3
- 229940041514 candida albicans extract Drugs 0.000 claims description 3
- AIMMVWOEOZMVMS-UHFFFAOYSA-N cyclopropanecarboxamide Chemical compound NC(=O)C1CC1 AIMMVWOEOZMVMS-UHFFFAOYSA-N 0.000 claims description 3
- 239000000344 soap Substances 0.000 claims description 3
- 229940082787 spirulina Drugs 0.000 claims description 3
- 239000012138 yeast extract Substances 0.000 claims description 3
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims description 2
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 2
- 240000008866 Ziziphus nummularia Species 0.000 claims description 2
- 235000013351 cheese Nutrition 0.000 claims description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims 3
- 241000186000 Bifidobacterium Species 0.000 claims 1
- 241000186660 Lactobacillus Species 0.000 claims 1
- 241000186605 Lactobacillus paracasei Species 0.000 claims 1
- 229940039696 lactobacillus Drugs 0.000 claims 1
- 230000036541 health Effects 0.000 abstract description 18
- 230000008451 emotion Effects 0.000 abstract description 11
- 208000019901 Anxiety disease Diseases 0.000 abstract description 8
- 230000036506 anxiety Effects 0.000 abstract description 8
- 230000002996 emotional effect Effects 0.000 abstract description 8
- 230000003340 mental effect Effects 0.000 abstract description 8
- 230000002708 enhancing effect Effects 0.000 abstract description 5
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 230000004630 mental health Effects 0.000 abstract description 4
- 241000894006 Bacteria Species 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 7
- 239000013589 supplement Substances 0.000 description 6
- 235000013616 tea Nutrition 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 206010022998 Irritability Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 244000057717 Streptococcus lactis Species 0.000 description 3
- 235000014897 Streptococcus lactis Nutrition 0.000 description 3
- 239000005515 coenzyme Substances 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 235000008160 pyridoxine Nutrition 0.000 description 3
- 239000011677 pyridoxine Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- 102000040350 B family Human genes 0.000 description 2
- 108091072128 B family Proteins 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 2
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 2
- 206010026749 Mania Diseases 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 206010047623 Vitamin C deficiency Diseases 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 238000013528 artificial neural network Methods 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 230000019522 cellular metabolic process Effects 0.000 description 2
- 235000019504 cigarettes Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 235000020774 essential nutrients Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000005802 health problem Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 229940029329 intrinsic factor Drugs 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 108010070915 orgotein Proteins 0.000 description 2
- 229960004534 orgotein Drugs 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 229960003581 pyridoxal Drugs 0.000 description 2
- 235000008164 pyridoxal Nutrition 0.000 description 2
- 239000011674 pyridoxal Substances 0.000 description 2
- 235000008151 pyridoxamine Nutrition 0.000 description 2
- 239000011699 pyridoxamine Substances 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 2
- 208000010233 scurvy Diseases 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- TUGDLVFMIQZYPA-UHFFFAOYSA-N tetracopper;tetrazinc Chemical compound [Cu+2].[Cu+2].[Cu+2].[Cu+2].[Zn+2].[Zn+2].[Zn+2].[Zn+2] TUGDLVFMIQZYPA-UHFFFAOYSA-N 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- TWNIBLMWSKIRAT-RWOPYEJCSA-N (1r,2s,3s,4s,5r)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol Chemical compound O1[C@@]2([H])OC[C@]1([H])[C@@H](O)[C@H](O)[C@@H]2O TWNIBLMWSKIRAT-RWOPYEJCSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000027534 Emotional disease Diseases 0.000 description 1
- 102000009025 Endorphins Human genes 0.000 description 1
- 108010049140 Endorphins Proteins 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010018873 Haemoconcentration Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000711549 Hepacivirus C Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 208000031845 Pernicious anaemia Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 241000235342 Saccharomycetes Species 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- 208000007642 Vitamin B Deficiency Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 210000004227 basal ganglia Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000036983 biotransformation Effects 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 210000001638 cerebellum Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000005314 correlation function Methods 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 210000001320 hippocampus Anatomy 0.000 description 1
- 235000006486 human diet Nutrition 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000000642 iatrogenic effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- JDNTWHVOXJZDSN-UHFFFAOYSA-N iodoacetic acid Chemical compound OC(=O)CI JDNTWHVOXJZDSN-UHFFFAOYSA-N 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- XRRQZKOZJFDXON-UHFFFAOYSA-N nitric acid;silver Chemical compound [Ag].O[N+]([O-])=O XRRQZKOZJFDXON-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- CPNGPNLZQNNVQM-UHFFFAOYSA-N pteridine Chemical compound N1=CN=CC2=NC=CN=C21 CPNGPNLZQNNVQM-UHFFFAOYSA-N 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 210000001103 thalamus Anatomy 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 108010050939 thrombocytin Proteins 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/121—Brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/125—Casei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/137—Delbrueckii
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/143—Fermentum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/181—Salivarius
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/231—Lactis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/513—Adolescentes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/517—Bifidum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/529—Infantis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明涉及一种五环互促微生组调节情绪的药食及其制备方法，包括神经递质促进组、微生物组、益生元促进组、益智健脑组、代谢修复组共五组功能组分，五组功能组分分别具有不同的功用，其相互促进作用多方面缓解焦虑、忧郁、心神不宁等心理情绪问题，通过调节情绪健康，增强意志，提高注意力来达到身心健康的目的，缓解情绪心理原因引起的人体亚健康。
Description
技术领域
本发明涉及药食技术领域，具体涉及一种五环互促微生组调节情绪的药食及其制备方法。
背景技术
人除了需要糖、脂肪和蛋白质，还需要的矿物质和营养元素。矿物质和营养元素大部分来自于食物。但是快节奏的生活使得很多人饮食不规律，经常处于亚健康状态。另外饮食结构精细化、与医源性过度治疗等造成人体内微生物生态失衡，以及生活水平的提高，与生活节奏的加快，工作压力的加大，容易使人产生不良的心理情绪，和不健康心理及早期忧郁症表现。不利于身心的健康。由于体内微生态的不健康失衡，身体内神经递质元素、促进大脑营养物质合成元素缺失造成的心理情绪的焦虑、忧郁、易怒、易躁等问题比比皆是，已成为大部分人群的问题。
现有的益生菌食品与调节肠胃道微生物生态健康产品，缺乏专门针对情绪健康产品解决方案，而且不能综合相互促进的方式解决心理情绪健康问题，功能单一，相关功能食品缺失，缺乏全方面综合解决方案。
发明内容
针对上述技术问题，本发明所要解决的技术问题是提供一种综合互促全面调节人体健康，消除情绪心理原因引起的人体亚健康，以及消除心理情绪的焦虑、忧郁、易怒、易躁等问题的五环互促微生组调节情绪的药食及其制备方法。
本发明解决上述技术问题的技术方案如下：
一种五环互促微生组调节情绪的药食，其特征在于，包括五组功能组分，分别为：
神经递质促进组：磷脂酰丝氨酸、γ-氨基丁酸、5-羟基色氨酸、茶氨酸、酸枣仁中的一种或者任意几种的组合；
微生物组：青春双歧杆菌、长双歧杆菌、婴儿双歧杆菌、两歧双歧杆菌、乳双歧杆菌、干酪乳杆菌、嗜酸乳杆菌、发酵乳杆菌、植物乳杆菌、唾液乳杆菌、短乳杆菌、鼠李糖乳杆菌、德式乳杆菌亚种、乳酸乳球菌乳酸亚种中的一种或者任意几种的组合；
益生元促进组：低聚异麦芽糖、大豆低聚糖、茶多酚、银耳多糖、薄荷、菊粉中的一种或任意几种的组合；
益智健脑组：二十二碳六烯酸、α-亚麻酸、原花青素、肌醇中的一种或任意几种的组合；
代谢修复组：谷胱甘肽、超氧化物歧化酶、维生素B1、维生素B6、叶酸、泛酸钙、烟酸、维生素B12、维生素C中的一种或任意几种的组合。
所述γ-氨基丁酸为乳酸菌发酵提取物。
所述原花青素为葡萄籽提取物。
所述谷胱甘肽为酵母提取物；
所述磷脂酰丝氨酸为大豆提取物；
所述维生素为C针叶樱桃提取物；
所述超氧化物歧化酶为螺旋藻取物或针叶樱桃提取物；
所述银耳多糖为银耳提取物；
所述茶氨酸为茶叶取物；
所述5-羟基色氨酸为加纳籽提取物；
所述酸枣仁为酸枣仁粉或酸枣仁提取物酸枣仁皂。
进一步，所述五组功能组分中各物质的重量份数分别为：磷脂酰丝氨酸1-1.5份、γ-氨基丁酸1.5-2份、茶氨酸1-1.5份、5-羟基色氨酸1-1.5份、酸枣仁1-1.4份、青春双歧杆菌5-6份、长双歧杆菌1-6份、婴儿双歧杆菌5-6份、两歧双歧杆菌5-6份、乳双歧杆菌3-8份、干酪乳杆菌4-6份、嗜酸乳杆菌4-6份、发酵乳杆菌4-6份、植物乳杆菌4-5.5份、唾液乳杆菌4-5.8份、短乳杆菌4-6份、鼠李糖乳杆菌4-6份、德式乳杆菌亚种4-6份、乳酸乳球菌乳酸亚种4-5.5份、低聚异麦芽糖1.5-2份、大豆低聚糖1.5-1.7份、茶多酚1.5-2份、银耳多糖1.5-1.7份、菊粉1-1.5份、薄荷0.1-0.6份、DHA二十二碳六烯酸1-1.55份、α-亚麻酸1.2-1.4份、原花青素1.2-1.4份、肌醇0.6-1份、谷胱甘肽1.2-1.4份、超氧化物歧化酶1.2-1.4份、维生素B10.7-0.9份、维生素B6为0.7-0.9份、叶酸0.7-0.9份、泛酸钙0.7-0.9份、烟酸0.7-0.9份、维生素B12为0.7-0.9份、维生素C为0.9-1.05份。
进一步，磷脂酰丝氨酸1.3份、γ-氨基丁酸1.8份、茶氨酸1.3份、5-羟基色氨酸1.1份、酸枣仁1.3份、青春双歧杆菌5.5份、长双歧杆菌5.5份、婴儿双歧杆菌5.5份、两歧双歧杆菌5份、乳双歧杆菌5份、干酪乳杆菌5份、嗜酸乳杆菌5份、发酵乳杆菌5份、植物乳杆菌5份、唾液乳杆菌5份、短乳杆菌5份、鼠李糖乳杆菌5份、德式乳杆菌亚种5份、乳酸乳球菌乳酸亚种5份、低聚异麦芽糖1.8份、大豆低聚糖1.6份、茶多酚1.6份、银耳多糖1.6份、菊粉1.35份、薄荷0.5份、DHA二十二碳六烯酸1.45份、α-亚麻酸1.3份、原花青素1.3份、肌醇0.8份、谷胱甘肽1.3份、超氧化物歧化酶1.3份、维生素B1为0.8份、维生素B6为0.8份、叶酸0.8份、泛酸钙0.8份、烟酸0.8份、维生素B12为0.8份和维生素C为1份。
五环互促微生组调节情绪药食的制备方法，其特征在于，将所述神经递质促进组、益生元促进组、益智健脑组和代谢修复组成粉后混合，并包装成A包装；
所述微生物组磨成粉后包装成B包装；A包装和B包装组合食用，A包装和B包装中还可以分别添加食品辅食后包装。
五环互促微生组调节情绪药食的制备方法，其特征在于，将所述神经递质促进组、益生元促进组、益智健脑组、代谢修复组和微生物组成粉后包装，还可以在包装内添加食品辅食。
有益效果：神经递质促进组用于补充和促进生成神经递质营养元素；微生物组用于调节肠胃道内分泌神经递质元素的微生物群，调节微生态平衡健康；益生元促进组用于补充益生元成分的促进微生态健康；益智健脑组用于促进神经元生长，增强神经组可塑性；代谢修复组用于调节促进细胞代谢、自由基代谢增强细胞活力、自愈免疫能力。五组功能组分相互促进作用多方面缓解焦虑、忧郁、易怒、易躁、心神不宁等心理情绪问题，通过调节情绪健康，增强意志，提高注意力来达到身心健康的目的，缓解人体亚健康。
神经递质促进组、益生元促进组、益智健脑组和代谢修复组磨成粉后混合，并包装成A包装；微生物组成粉后包装成B包装；A包装和B包装分开组装，便于生产。
神经递质促进组、益生元促进组、益智健脑组、代谢修复组和微生物组也可以混合，食用方便，还可以在上述五组功能组分中添加食品辅食。
具体实施方式
以下对本发明的原理和特征进行描述，所举实例只用于解释本发明，并非用于限定本发明的范围。
一种五环互促微生组调节情绪的药食，包括五组功能组分，分别为：
神经递质促进组：磷脂酰丝氨酸、γ-氨基丁酸、5-羟基色氨酸、茶氨酸、酸枣仁中的一种或者任意几种的组合；
微生物组：青春双歧杆菌、长双歧杆菌、婴儿双歧杆菌、两歧双歧杆菌、乳双歧杆菌、干酪乳杆菌、嗜酸乳杆菌、发酵乳杆菌、植物乳杆菌、唾液乳杆菌、短乳杆菌、鼠李糖乳杆菌、德式乳杆菌亚种、乳酸乳球菌乳酸亚种中的一种或者任意几种的组合；
益生元促进组：低聚异麦芽糖、大豆低聚糖、茶多酚、银耳多糖、薄荷、菊粉中的一种或任意几种的组合；
益智健脑组：二十二碳六烯酸、α-亚麻酸、原花青素、肌醇中的一种或任意几种的组合；
代谢修复组：谷胱甘肽、超氧化物歧化酶、维生素B1、维生素B6、叶酸、泛酸钙、烟酸、维生素B12、维生素C中的一种或任意几种的组合。
γ-氨基丁酸为乳酸菌发酵提取物；所述原花青素为葡萄籽提取物。所述的原花青素为葡萄籽提取物。原花青素，简称OPC，是一种有着特殊分子结构的生物类黄酮，是目前公认的清除人体内自由基最有效的天然抗氧化剂。一般为红棕色粉末，气微、味涩，溶于水和大多有机溶剂。蓝莓叶提取物原花青素可阻止丙肝病毒复制。是一种有着特殊分子结构的生物类黄酮，是人体内自由基有效的抗氧化剂。一般为葡萄籽提取物或松树皮提取物。原花青素(葡萄籽提取物)是一种新型高效抗氧化剂，是强效的自由基清除剂，具有非常强的体内活性。实验证明，OPC的抗自由基氧化能力是维生素E的50倍，维生素C的20倍，并吸收迅速完全，口服20分钟即可达到最高血液浓度，代谢半衰期达7小时之久。
所述谷胱甘肽为酵母提取物；谷胱甘肽(glutathione，GSH)是由谷氨酸、半胱氨酸和甘氨酸结合，含有巯基的的三肽，具有抗氧化作用和整合解毒作用。半胱氨酸上的巯基为谷胱甘肽活性基团(故谷胱甘肽常简写为G-SH)，易与某些药物(如扑热息痛)、毒素(如自由基、碘乙酸、芥子气，铅、汞、砷等重金属)等结合，而具有整合解毒作用。故谷胱甘肽(尤其是肝细胞内的谷胱甘肽)能参与生物转化作用，从而把机体内有害的毒物转化为无害的物质，排泄出体外。谷胱甘肽还能帮助保持正常的免疫系统的功能。磷脂酰丝氨酸为大豆提取物；所述维生素为C针叶樱桃提取物；维生素C(英语：Vitamin C，又称L-抗坏血酸)，是高等灵长类动物与其他少数生物的必需营养素。抗坏血酸在大多的生物体可借由新陈代谢制造出来，但是人类是最显著的例外。缺乏维生素C会造成坏血病。在生物体内，维生素C是一种抗氧化剂，保护身体免于自由基的威胁，维生素C同时也是一种辅酶。其广泛的食物来源为各类新鲜蔬果。
超氧化物歧化酶为螺旋藻取物或针叶樱桃提取物；超氧化物歧化酶Orgotein(Superoxide Dismutase，SOD)，别名肝蛋白、简称：SOD。是一种源于生命体的活性物质，能消除生物体在新陈代谢过程中产生的有害物质。对人体不断地补充SOD具有抗衰老的特殊效果。
银耳多糖为银耳提取物；银耳多糖(Tremella fuciformisBerk)，俗称白木耳，子实体中得到银耳多糖(Tremellam)是一种酸性杂多糖，其主链结构是由α-(1→3)糖苷键连接的甘露聚糖，支链由葡萄糖醛酸和木糖组成。存在于银耳深层发酵孢子体中的酸性杂多糖，主链结构与上述相似，仅在支链上有所区别。
维生素B1又称硫胺素或抗神经炎维生素或抗脚气病维生素，为白色晶体，在有氧化剂存在时容易被氧化产生脱氢硫胺素，后者在有紫外光照射时呈现蓝色荧光。由嘧啶环和噻唑环通过亚甲基结合而成的一种B族维生素。
维生素B6(Vitamin B6)又称吡哆素，其包括吡哆醇、吡哆醛及吡哆胺，在体内以磷酸酯的形式存在，是一种水溶性维生素，遇光或碱易破坏，不耐高温。1936年定名为维生素B6。维生素B6为无色晶体，易溶于水及乙醇，在酸液中稳定，在碱液中易破坏，吡哆醇耐热，吡哆醛和吡哆胺不耐高温。维生素B6在酵母菌、肝脏、谷粒、肉、鱼、蛋、豆类及花生中含量较多。维生素B6为人体内某些辅酶的组成成分，参与多种代谢反应，尤其是和氨基酸代谢有密切关系。
维生素B2(化学式：C17H20N406，式量376.37)，又叫核黄素，微溶于水，在中性或酸性溶液中加热是稳定的。为体内黄酶类辅基的组成部分(黄酶在生物氧化还原中发挥递氢作用)，当缺乏时，就影响机体的生物氧化，使代谢发生障碍。
叶酸(VB9)又称蝶酰谷氨酸，叶酸由蝶啶、对氨基苯甲酸和L-谷氨酸组成，也叫蝶酰谷氨酸，它是B族维生素的一种。
泛酸(VB5)为泛酸钙，泛酸钙易溶于水和甘油，不溶于酒精、氯仿和乙醚。用于医药、食品及饲料添加剂。是辅酶A的成分，参与碳水化合物、脂肪和蛋白质的代谢作用，临床用于治疗维生素B缺乏症，周围神经炎，手术后肠绞痛。参与蛋白质、脂肪、糖在体内的新陈代谢。
烟酸(VB3)为烟酰胺，烟酰胺品在水或乙醇中易溶，在甘油中溶解；在乙醚中几乎不溶；在碳酸钠试液或氢氧化钠试液中易溶。
维生素B12又叫钴胺素，是唯一含金属元素的维生素。自然界中的维生素B12都是微生物合成的，高等动植物不能制造维生素B12。维生素B12是惟一的一种需要一种肠道分泌物(内源因子)帮助才能被吸收的维生素。有的人由于肠胃异常，缺乏这种内源因子，即使膳食中来源充足也会患恶性贫血。
维生素C(英语：Vitamin C，又称L-抗坏血酸)，是高等灵长类动物与其他少数生物的必需营养素。抗坏血酸在大多的生物体可借由新陈代谢制造出来，但是人类是最显著的例外。缺乏维生素C会造成坏血病。在生物体内，维生素C是一种抗氧化剂，保护身体免于自由基的威胁，维生素C同时也是一种辅酶。
肌醇广泛分布在动物和植物体内，是动物、微生物的生长因子。从心肌和肝脏中分离得到。环己六醇在自然界存在有多个顺、反异构体，天然存在的异构体为顺-1，2，3，5-反-4，6-环己六醇。
茶氨酸为茶叶取物；5-羟基色氨酸为加纳籽提取物；酸枣仁为酸枣仁粉或酸枣仁提取物酸枣仁皂。
本发明加入到食品或饮料(包括固体饮料)内，可多方面缓解焦虑、忧郁、狂躁、易怒、易躁、心神不宁等心理情绪问题，通过调节情绪健康，增强意志，提高注意力来达到身心健康的目的，缓解情绪心理原因引起的亚健康问题。
如：通常心情忧郁和体内的自由基有关，本发明配方可清除自由基抗氧化成分。
通过补充和促进生成γ-氨基丁酸、内啡肽、多巴胺、血清素等神经递质营养元素调节情绪健康微生态情绪健康调节，通过调节肠胃道内分泌神经递质元素的微生物群，调节微生态平衡健康。脑肠轴微生态的健康对情绪和智力有着密切的关联，调节肠道微生物健康对情绪理智有着显著积极影响。抑制有害菌数量，补充益生元成分的促进微生态情绪健康。
补充神经细胞生长所需营养成分和促进神经元生成，健脑益智，增强神经网络的可塑性。
调节促进细胞代谢、自由基代谢增强细胞活力、自愈免疫能力以促进情绪健康。
五组功能元素相互促进作用多方面缓解焦虑、忧郁、易怒、易躁、心神不宁等心理情绪问题，通过调节情绪健康，增强意志，提高注意力来达到身心健康的目的。
补充体能跟神经系统有关的维生素，避免因维生素缺乏造成的不良情绪。
补充中枢神经gaba(γ-氨基丁酸：约30％的突触部位以GABA为递质。在人体大脑皮质、海马、丘脑、基底神经节和小脑中起重要作用，并对机体的多种功能具有调节作用。当人体内GABA缺乏时，会产生焦虑、不安、疲倦、忧虑等情绪。)避免因因此引起了的不良情绪。
薄荷等口感起到清凉、醒目、提神作用，调节不良情绪状态。薄荷，土名叫“银丹草”，为唇形科植物，即同属其他干燥全草，多生于山野湿地河旁，根茎横生地下，多生于2100米海拔高度，但也可在3500米海拔上生长，是一种有特种经济价值的芳香作物。全株青气芳香。叶对生，花小淡紫色，唇形，花后结暗紫棕色的小粒果。薄荷是辛凉性发汗解热药，治流行性感冒、头疼、目赤、身热、咽喉、牙床肿痛等症。外用可治神经痛、皮肤瘙痒、皮疹和湿疹等。光朋温室采摘的薄荷又是春节餐桌上的鲜菜。
本发明可以起到从以上多方面缓解焦虑、忧郁、狂躁，心神不宁等心理情绪问题，通过调节情绪健康，增强神经网络的可塑性，增强意志提高注意力来达到身心健康的目的，有利于促进人体身心健康。
其中五组功能组分中各物质的重量份数分别为：磷脂酰丝氨酸1-1.5份、γ-氨基丁酸1.5-2份、茶氨酸1-1.5份、5-羟基色氨酸1-1.5份、酸枣仁1-1.4份、青春双歧杆菌5-6份、长双歧杆菌1-6份、婴儿双歧杆菌5-6份、两歧双歧杆菌5-6份、乳双歧杆菌3-8份、干酪乳杆菌4-6份、嗜酸乳杆菌4-6份、发酵乳杆菌4-6份、植物乳杆菌4-5.5份、唾液乳杆菌4-5.8份、短乳杆菌4-6份、鼠李糖乳杆菌4-6份、德式乳杆菌亚种4-6份、乳酸乳球菌乳酸亚种4-5.5份、低聚异麦芽糖1.5-2份、大豆低聚糖1.5-1.7份、茶多酚1.5-2份、银耳多糖1.5-1.7份、菊粉1-1.5份、薄荷0.1-0.6份、DHA二十二碳六烯酸1-1.55份、α-亚麻酸1.2-1.4份、原花青素1.2-1.4份、肌醇0.6-1份、谷胱甘肽1.2-1.4份、超氧化物歧化酶1.2-1.4份、维生素B10.7-0.9份、维生素B6为0.7-0.9份、叶酸0.7-0.9份、泛酸钙0.7-0.9份、烟酸0.7-0.9份、维生素B12为0.7-0.9份、维生素C为0.9-1.05 份。采用该配比的方案，可以根据不同年龄和体质的人的需求灵活选取，满足大部分人的需求需求。
优选方案：磷脂酰丝氨酸1.3份、γ-氨基丁酸1.8份、茶氨酸1.3份、5-羟基色氨酸1.1份、酸枣仁1.3份、青春双歧杆菌5.5份、长双歧杆菌5.5份、婴儿双歧杆菌5.5份、两歧双歧杆菌5份、乳双歧杆菌5份、干酪乳杆菌5份、嗜酸乳杆菌5份、发酵乳杆菌5份、植物乳杆菌5份、唾液乳杆菌5份、短乳杆菌5份、鼠李糖乳杆菌5份、德式乳杆菌亚种5份、乳酸乳球菌乳酸亚种5份、低聚异麦芽糖1.8份、大豆低聚糖1.6份、茶多酚1.6份、银耳多糖1.6份、菊粉1.35份、薄荷0.5份、DHA二十二碳六烯酸1.45份、α-亚麻酸1.3份、原花青素1.3份、肌醇0.8份、谷胱甘肽1.3份、超氧化物歧化酶1.3份、维生素B1为0.8份、维生素B6为0.8份、叶酸0.8份、泛酸钙0.8份、烟酸0.8份、维生素B12为0.8份和维生素C为1份。采用该优选方案，能够最好的满足大部分人的需求，配比合理。
最后，以上仅为本发明的较佳实施例，并不用以限制本发明，凡在本发明的精神和原则之内，所作的任何修改、等同替换、改进等，均应包含在本发明的保护范围之内。
Claims (8)
1.一种五环互促微生组调节情绪的药食，其特征在于，包括五组功能组分，分别为：
神经递质促进组：磷脂酰丝氨酸、γ-氨基丁酸、5-羟基色氨酸、茶氨酸、酸枣仁中的一种或者任意几种的组合；
微生物组：青春双歧杆菌、长双歧杆菌、婴儿双歧杆菌、两歧双歧杆菌、乳双歧杆菌、干酪乳杆菌、嗜酸乳杆菌、发酵乳杆菌、植物乳杆菌、唾液乳杆菌、短乳杆菌、鼠李糖乳杆菌、德式乳杆菌亚种、乳酸乳球菌乳酸亚种中的一种或者任意几种的组合；
益生元促进组：低聚异麦芽糖、大豆低聚糖、茶多酚、银耳多糖、薄荷、菊粉中的一种或任意几种的组合；
益智健脑组：二十二碳六烯酸、α-亚麻酸、原花青素、肌醇中的一种或任意几种的组合；
代谢修复组：谷胱甘肽、超氧化物歧化酶、维生素B1、维生素B6、叶酸、泛酸钙、烟酸、维生素B12、维生素C中的一种或任意几种的组合。
2.根据权利要求1所述的五环互促微生组调节情绪的药食，其特征在于，所述γ-氨基丁酸为乳酸菌发酵提取物。
3.根据权利要求1所述的五环互促微生组调节情绪的药食，其特征在于，所述原花青素为葡萄籽提取物。
4.根据权利要求1所述的五环互促微生组调节情绪的药食，其特征在于，
所述谷胱甘肽为酵母提取物；
所述磷脂酰丝氨酸为大豆提取物；
所述维生素为C针叶樱桃提取物；
所述超氧化物歧化酶为螺旋藻取物或针叶樱桃提取物；
所述银耳多糖为银耳提取物；
所述茶氨酸为茶叶取物；
所述5-羟基色氨酸为加纳籽提取物；
所述酸枣仁为酸枣仁粉或酸枣仁提取物酸枣仁皂。
5.根据权利要求1所述的五环互促微生组调节情绪的药食，其特征在于，所述五组功能组分中各物质的重量份数分别为：磷脂酰丝氨酸1-1.5份、γ-氨基丁酸1.5-2份、茶氨酸1-1.5份、5-羟基色氨酸1-1.5份、酸枣仁1-1.4份、青春双歧杆菌5-6份、长双歧杆菌1-6份、婴儿双歧杆菌5-6份、两歧双歧杆菌5-6份、乳双歧杆菌3-8份、干酪乳杆菌4-6份、嗜酸乳杆菌4-6份、发酵乳杆菌4-6份、植物乳杆菌4-5.5份、唾液乳杆菌4-5.8份、短乳杆菌4-6份、鼠李糖乳杆菌4-6份、德式乳杆菌亚种4-6份、乳酸乳球菌乳酸亚种4-5.5份、低聚异麦芽糖1.5-2份、大豆低聚糖1.5-1.7份、茶多酚1.5-2份、银耳多糖1.5-1.7份、菊粉1-1.5份、薄荷0.1-0.6份、DHA二十二碳六烯酸1-1.55份、α-亚麻酸1.2-1.4份、原花青素1.2-1.4份、肌醇0.6-1份、谷胱甘肽1.2-1.4份、超氧化物歧化酶1.2-1.4份、维生素B1 0.7-0.9份、维生素B6为0.7-0.9份、叶酸0.7-0.9份、泛酸钙0.7-0.9份、烟酸0.7-0.9份、维生素B12为0.7-0.9份、维生素C为0.9-1.05份。
6.根据权利要求5所述的五环互促微生组调节情绪的药食，其特征在于，磷脂酰丝氨酸1.3份、γ-氨基丁酸1.8份、茶氨酸1.3份、5-羟基色氨酸1.1份、酸枣仁1.3份、青春双歧杆菌5.5份、长双歧杆菌5.5份、婴儿双歧杆菌5.5份、两歧双歧杆菌5份、乳双歧杆菌5份、干酪乳杆菌5份、嗜酸乳杆菌5份、发酵乳杆菌5份、植物乳杆菌5份、唾液乳杆菌5份、短乳杆菌5份、鼠李糖乳杆菌5份、德式乳杆菌亚种5份、乳酸乳球菌乳酸亚种5份、低聚异麦芽糖1.8份、大豆低聚糖1.6份、茶多酚1.6份、银耳多糖1.6份、菊粉1.35份、薄荷0.5份、DHA二十二碳六烯酸1.45份、α-亚麻酸1.3份、原花青素1.3份、肌醇0.8份、谷胱甘肽1.3份、超氧化物歧化酶1.3份、维生素B1为0.8份、维生素B6为0.8份、叶酸0.8份、泛酸钙0.8份、烟酸0.8份、维生素B12为0.8份和维生素C为1份。
7.五环互促微生组调节情绪药食的制备方法，其特征在于，将所述神经递质促进组、益生元促进组、益智健脑组和代谢修复组磨成粉后混合，并包装成A包装；
所述微生物组成粉后包装成B包装；A包装和B包装组合食用。
8.五环互促微生组调节情绪药食的制备方法，其特征在于，将所述神经递质促进组、益生元促进组、益智健脑组、代谢修复组和微生物组成粉后包装。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710021235.2A CN106880050A (zh) | 2017-01-12 | 2017-01-12 | 一种五环互促微生组调节情绪的药食及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710021235.2A CN106880050A (zh) | 2017-01-12 | 2017-01-12 | 一种五环互促微生组调节情绪的药食及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106880050A true CN106880050A (zh) | 2017-06-23 |
Family
ID=59176384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710021235.2A Pending CN106880050A (zh) | 2017-01-12 | 2017-01-12 | 一种五环互促微生组调节情绪的药食及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106880050A (zh) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109043548A (zh) * | 2018-08-21 | 2018-12-21 | 广州能靓生物技术有限公司 | 一种组合物、美容养颜、延缓衰老的产品及应用 |
| CN109730309A (zh) * | 2019-01-10 | 2019-05-10 | 蕴彤本草(北京)生物科技有限公司 | 健脑益智安神缓解压力益智仁复合多肽营养素及制备方法 |
| CN110915887A (zh) * | 2019-12-03 | 2020-03-27 | 华南农业大学 | 一种复合生物保鲜剂及其应用 |
| CN111480842A (zh) * | 2020-04-17 | 2020-08-04 | 上海复旦奥医医学科技有限公司 | 一种焦虑抑郁专用型医学营养配方及其制备方法 |
| CN114917255A (zh) * | 2022-06-09 | 2022-08-19 | 比菲德(北京)生物科技有限公司 | 一种可缓解自闭症并调节情绪的益生菌粉及其应用 |
| EP4176890A1 (en) * | 2021-11-03 | 2023-05-10 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Oxytocin-mimetic compositions and uses thereof |
| WO2023079036A1 (en) * | 2021-11-03 | 2023-05-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Probiotic composition comprising a lactobacillus salivarius strain, a lactobacillus camelliae strain and a bifidobacterium ruminantium strain |
| CN116726054A (zh) * | 2022-12-05 | 2023-09-12 | 山东新时代药业有限公司 | 一种即食型益生菌组合物及其制备方法、用途 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104146262A (zh) * | 2013-12-18 | 2014-11-19 | 胡安然 | 一种调理气郁体质的膳食 |
| CN104839672A (zh) * | 2015-04-13 | 2015-08-19 | 劲膳美生物科技股份有限公司 | 气郁体质医学配方食品 |
-
2017
- 2017-01-12 CN CN201710021235.2A patent/CN106880050A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104146262A (zh) * | 2013-12-18 | 2014-11-19 | 胡安然 | 一种调理气郁体质的膳食 |
| CN104839672A (zh) * | 2015-04-13 | 2015-08-19 | 劲膳美生物科技股份有限公司 | 气郁体质医学配方食品 |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109043548A (zh) * | 2018-08-21 | 2018-12-21 | 广州能靓生物技术有限公司 | 一种组合物、美容养颜、延缓衰老的产品及应用 |
| CN109043548B (zh) * | 2018-08-21 | 2021-12-24 | 广州能靓生物技术有限公司 | 一种组合物、美容养颜、延缓衰老的产品及应用 |
| CN109730309A (zh) * | 2019-01-10 | 2019-05-10 | 蕴彤本草(北京)生物科技有限公司 | 健脑益智安神缓解压力益智仁复合多肽营养素及制备方法 |
| CN110915887A (zh) * | 2019-12-03 | 2020-03-27 | 华南农业大学 | 一种复合生物保鲜剂及其应用 |
| CN110915887B (zh) * | 2019-12-03 | 2021-09-14 | 华南农业大学 | 一种复合生物保鲜剂及其应用 |
| CN111480842A (zh) * | 2020-04-17 | 2020-08-04 | 上海复旦奥医医学科技有限公司 | 一种焦虑抑郁专用型医学营养配方及其制备方法 |
| EP4176890A1 (en) * | 2021-11-03 | 2023-05-10 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Oxytocin-mimetic compositions and uses thereof |
| WO2023079036A1 (en) * | 2021-11-03 | 2023-05-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Probiotic composition comprising a lactobacillus salivarius strain, a lactobacillus camelliae strain and a bifidobacterium ruminantium strain |
| WO2023078603A1 (en) * | 2021-11-03 | 2023-05-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Oxytocin-mimetic compositions and uses thereof |
| CN114917255A (zh) * | 2022-06-09 | 2022-08-19 | 比菲德(北京)生物科技有限公司 | 一种可缓解自闭症并调节情绪的益生菌粉及其应用 |
| CN116726054A (zh) * | 2022-12-05 | 2023-09-12 | 山东新时代药业有限公司 | 一种即食型益生菌组合物及其制备方法、用途 |
| CN116726054B (zh) * | 2022-12-05 | 2024-03-26 | 山东新时代药业有限公司 | 一种即食型益生菌组合物及其制备方法、用途 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106880050A (zh) | 一种五环互促微生组调节情绪的药食及其制备方法 | |
| Beheshtipour et al. | Supplementation of Spirulina platensis and Chlorella vulgaris algae into probiotic fermented milks | |
| Kantachote et al. | The use of potential probiotic Lactobacillus plantarum DW12 for producing a novel functional beverage from mature coconut water | |
| CN103027231B (zh) | 一种复合益生菌发酵中草药活性保健液及其制备方法 | |
| CN105146614B (zh) | 一种功能性钙果酵素、酵素饮料及其生产方法 | |
| Kittibunchakul et al. | Health beneficial properties of a novel plant-based probiotic drink produced by fermentation of brown rice milk with GABA-producing Lactobacillus pentosus isolated from Thai pickled weed | |
| CN103582486B (zh) | 具有抗氧化活性的益生菌及其用途 | |
| CN109123295A (zh) | 一种益生菌固体饮料及其制备方法 | |
| CN105167072A (zh) | 一种功能性枸杞酵素及其制品的生产方法 | |
| CN108244252A (zh) | 益生菌多元蛋白粉及其制备方法 | |
| CN106376917A (zh) | 一种从多方面调节情绪的保健食品或饮料配方 | |
| CN105231444A (zh) | 一种代餐组合酵素及其制备方法 | |
| CN108634151A (zh) | 一种益生菌鸡蛋营养粉及其制备方法 | |
| CN103431467A (zh) | 芦笋提取物双岐益生菌发酵活性饮料及其制备方法 | |
| CN106858577A (zh) | 制备具有保肝护肝、调节脂肪肝代谢功能的植物酵素的发酵组合物及制法 | |
| KR101664380B1 (ko) | 황국균 및 유산균 복합발효기술을 이용한 홍삼을 함유하는 발효 효소 식품의 제조 방법 | |
| JP4119656B2 (ja) | 抗酸化剤 | |
| CN104382129A (zh) | 一种甜玉米红茶菌饮品 | |
| Phukon et al. | Microbial bioprocesses for production of nutraceuticals and functional foods | |
| KR102167812B1 (ko) | 장건강 및 장개선 효능을 가지는 수수 및 팥 발효물 및 이의 제조방법 | |
| Lokhande et al. | Immune boosting super food supplement from natural resources | |
| KR102450427B1 (ko) | 고양이 요로 감염 예방 및 비뇨기 기능 개선용 조성물 | |
| JP2010155789A (ja) | 肝機能障害改善剤 | |
| KR102160918B1 (ko) | 미생물 기반의 사료용 생균제 | |
| KR101252249B1 (ko) | 선옥균을 이용한 식품첨가용 발효 조성물과 그 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170623 |
|
| RJ01 | Rejection of invention patent application after publication |